Peter was Research Scientist II for X-Ceptor Therapeutics. Peter served as Vice President, Translational Medicine at Syndax Pharmaceuticals.
Peter Ordentlich is currently
Create your alert
to follow the career of Peter Ordentlich.
Peter Ordentlich has a PhD in Immunology from University of Pennsylvania and a Postdoctoral Fellow from Salk Institute.
They have also studied at University of Pennsylvania :
Find more alumni from University of Pennsylvania
Do you need to know more about Peter Ordentlich? More results.
Report an error
Update the org chart details of Peter Ordentlich.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.